Literature DB >> 17383330

Predictors of death and impact of surgery in Staphylococcus aureus infective endocarditis.

Jean Paul Remadi1, Gilbert Habib, Georges Nadji, Amel Brahim, Franck Thuny, Jean Paul Casalta, Marcel Peltier, Christophe Tribouilloy.   

Abstract

BACKGROUND: We studied a large cohort of adults with Staphylococcus aureus infective endocarditis to evaluate the predictors of outcome and to establish whether early surgery is associated with reduced mortality.
METHODS: The study prospectively enrolled 116 consecutive patients with definite S. aureus infective endocarditis, according to Duke criteria and examined by transthoracic and transesophageal echocardiography.
RESULTS: The in-hospital mortality rate was 26%, and the 36-month survival rate was 57% +/- 5%. Multivariate analyses identified comorbidity index, congestive heart failure, severe sepsis, prosthetic valve infective endocarditis, and major neurologic events as predictors of in-hospital mortality; severe sepsis and comorbidity index as predictors of overall mortality; and the comorbidity index as a predictor of late mortality. In unadjusted analyses, early surgery performed in 47% of patients was associated with lower in-hospital mortality (16% versus 34%; p = 0.034) and with better 36-month survival (77% +/- 6% versus 39% +/- 7%; p < 0.001). After adjustment of baseline variables related to mortality, early surgery remained associated with reduced overall mortality.
CONCLUSIONS: Prognosis of S. aureus infective endocarditis remains poor, related to the comorbidities, presence of congestive heart failure, severe sepsis, major neurologic events, and prosthetic valve. Early surgery is independently associated with reduced overall mortality and should be considered in selected cases to improve the outcome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17383330     DOI: 10.1016/j.athoracsur.2006.09.093

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  14 in total

1.  Successful treatment, despite a non-surgical approach, of severe infective endocarditis.

Authors:  Peter K Boulos; Mark Y Jeong
Journal:  BMJ Case Rep       Date:  2013-10-09

Review 2.  Infective endocarditis: therapeutic options and indications for surgery.

Authors:  Aneil Malhotra; Jenny Rayner; Timothy M Williams; Bernard Prendergast
Journal:  Curr Cardiol Rep       Date:  2014-04       Impact factor: 2.931

3.  The epidemiological and clinical features of odontogenic infective endocarditis.

Authors:  Ivana Šutej; Kristina Peroš; Vladimir Trkulja; Igor Rudež; Davor Barić; Ivan Alajbeg; Hrvoje Pintarić; Ranko Stevanović; Dragan Lepur
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-30       Impact factor: 3.267

4.  Multiple sites on Streptococcus gordonii surface protein PadA bind to platelet GPIIbIIIa.

Authors:  Ciara Keane; Helen J Petersen; Dorothea Tilley; Jennifer Haworth; Dermot Cox; Howard F Jenkinson; Steve W Kerrigan
Journal:  Thromb Haemost       Date:  2013-10-17       Impact factor: 5.249

5.  Continuous versus intermittent infusion of oxacillin for treatment of infective endocarditis caused by methicillin-susceptible Staphylococcus aureus.

Authors:  Darrel W Hughes; Christopher R Frei; Pamela R Maxwell; Kay Green; Jan E Patterson; George E Crawford; James S Lewis
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

Review 6.  Surgery in current therapy for infective endocarditis.

Authors:  Stuart J Head; M Mostafa Mokhles; Ruben L J Osnabrugge; Ad J J C Bogers; A Pieter Kappetein
Journal:  Vasc Health Risk Manag       Date:  2011-04-19

7.  Infective endocarditis complicated with left atrioventricular fistula in a 20-year-old patient. A case study.

Authors:  Andrzej Banyś; Witold Pawłowski; Sławomir Jander; Karol Bartczak; Marek Maciejewski; Ryszard Jaszewski
Journal:  Arch Med Sci       Date:  2011-12-30       Impact factor: 3.318

8.  Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy.

Authors:  Susan Rehm; Marilyn Campion; David E Katz; Rene Russo; Helen W Boucher
Journal:  J Antimicrob Chemother       Date:  2009-03-05       Impact factor: 5.790

9.  Clinical - microbiological characterization and risk factors of mortality in infective endocarditis from a tertiary care academic hospital in Southern India.

Authors:  Prasanna Subbaraju; Shipra Rai; Jwalit Morakhia; Geet Midha; Asha Kamath; Kavitha Saravu
Journal:  Indian Heart J       Date:  2017-08-16

10.  Risk stratification biomarkers for Staphylococcus aureus bacteraemia.

Authors:  Yi Cao; Alessander O Guimaraes; Melicent C Peck; Oleg Mayba; Felicia Ruffin; Kyu Hong; Montserrat Carrasco-Triguero; Vance G Fowler; Stacey A Maskarinec; Carrie M Rosenberger
Journal:  Clin Transl Immunology       Date:  2020-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.